Boston Scientific CMO Dr. Keith Dawkins says the medical device company is working on a renal denervation system to treat hypertension.
Heading into next week's Transcatheter Cardiovascular Therapies 2012 conference in Miami, the Natick, Mass.-based medical device company's global chief medical officer told us that BSX is planning to highlight several technologies at the show.
A single-electrode renal denervation system will go into its 1st human trials over "the next few months," Dawkins told us. Boston Scientific is also working on a double-electrode device, he added.
"We're looking at being able to reduce the time it takes to do an ablation," Dawkins said.